Hermann Luebbert - 18 May 2024 Form 4 Insider Report for Biofrontera Inc. (BFRI)

Role
CEO & Exec. Chairman, Director
Signature
/s/ Daniel Hakansson, Attorney-in-fact for Hermann Luebbert
Issuer symbol
BFRI
Transactions as of
18 May 2024
Net transactions value
$0
Form type
4
Filing time
22 May 2024, 16:45:41 UTC
Previous filing
22 May 2023
Next filing
16 Jul 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BFRI Common Stock Options Exercise +4,771 +46% 15,211 18 May 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BFRI Restricted Stock Units Options Exercise $0 -4,771 -100% $0.000000* 0 18 May 2024 Common Stock 4,771 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 On May 18, 2022, the reporting person was granted 9,542 restricted stock units, vesting in two equal annual installments beginning on May 18, 2023.

Remarks:

All share amounts have been adjusted for the reverse stock split that occurred on June 28, 2023.